Correlating breast cancer subtypes to clinical outcomes and targeted therapeutics in an era of personalized medicine
Discover how immunohistochemistry is supporting the identification of molecular subtypes of breast cancer
Discover how immunohistochemistry is supporting the identification of molecular subtypes of breast cancer
Seegene is to export COVID-19 tests along with its Master Assay that distinguishes between COVID-19 and other respiratory viruses
The technology provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise
Discover the latest tools and techniques to expand your research capacity with presentations from experts on immunotherapeutics, multiplexed assays, clinical analysis, and more
Study findings add to the evidence that vaccination during pregnancy does not increase the risk of complications in pregnancy but COVID-19 does
The artus® SARS-CoV-2 Prep&Amp UM cuts PCR processing times by two thirds
Explore how a partnership between a lead researcher in sexual health and a molecular diagnostics innovator helped to overcome the therapeutic hurdles that come with antibiotic resistance
The partnership aims to combine oncolytic viruses with Affibody® molecules
Avacta provides recent updates on the performance of its antigen lateral flow tests with the Omicron variant
University of Manchester researchers share findings from a study into the use of locum GPs in England
The partnership aims to distribute Nanotrap® Magnetic Virus Particles that provide rapid viral concentration directly from raw sewage.
Watch this on-demand webinar to find out how you can ensure product safety and quality of IVD products
Researchers were able to detect cell free RNA in the blood of pregnant women which provided a molecular signature to identify women at risk of pre-eclampsia
Discover the latest tools and techniques to advance your work with lessons from leading experts on therapeutic proteins, 3D disease models, clinical analysis, and more
Watch this on-demand webinar to learn more about the potential consequences of SARS-CoV-2 mutations and variants for vaccination status and lab testing
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure
The award comes after Avacta obtained regulatory approval for the Lateral Flow Test
Watch this on-demand webinar to find out the advantages of immunotyping over immunofixation in detecting M-proteins
The easy-to-use workflow can detect T-cell response early in the course of COVID-19 infection or following vaccination
Dr. Tania Nolan reveals the challenges of flu season uncertainty amid the COVID-19 pandemic and where combo testing could fit in
Discover a reliable and flexible approach for incorporating dried blood spot analysis into routine patient diagnostics